Reprieve Cardiovascular

Milford, MA · Founded 2018 · Privately Held (backing)

Developer of an acute decompensated heart failure (ADHF) treatment medical device designed to help patients experience life without limits. Reprieve Cardiovascular is based in Milford, MA and was founded in 2018. It was valued at $100 million at its later-stage round in Sep 2025, the last priced event on record. It has raised $103 million across 5 recorded rounds; the latest was a $30.9 million early-stage round in May 2025.

PMV mark · valuation
$100.0M
Oct 2026
Priced at
its later-stage round
Sep 2025
Total raised
$103.0M
Last round
Early Stage VC
May 2025

Who backs Reprieve Cardiovascular?

11 investors
InvestorType
Deerfield ManagementVenture capital
Arboretum VenturesVenture capital
Lightstone VenturesVenture capital
Abiomed—
Cadence Capital—
CareMax (US)—
Exigent Capital Group—
Genesis Capital—
Rex Health Ventures—
Santen Ventures—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Reprieve Cardiovascular investors

11 investors are on record for Reprieve Cardiovascular, including Deerfield Management, Arboretum Ventures, Lightstone Ventures and Abiomed. The early-stage round in May 2025 drew 12 investors.

Free account
More of Reprieve Cardiovascular with a free account
  • ·The complete investor list: 11 names
  • ·Watch Reprieve Cardiovascular: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Reprieve Cardiovascular. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View